CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market sale SVP, Chief Commercial Officer sold 7,474 shares at $28.26 ($211,203)
- 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 795 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 7,585 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 795 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,945 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 7,585 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 905 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 347 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,029 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 50,000 shares at $29.15 ($1,457,475)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $27.22 ($680,380)
- 4 Open-market sale Director and CEO, Alkermes plc sold 347,257 shares at an average $27.98 ($9,717,784)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $28.62 ($715,415)
- 4 Open-market sale Director sold 10,000 shares at $29.23 ($292,330)
Page 13 of 67 · 1,323 filings